Discover
SLS
SELLAS Life Sciences Group, Inc.
13.27
2 x 10.24
2 x 16.37
bid
ask
-
1.49
10.09%
2 @ 07:42 AM
13.25 -0.02 (0.15%)
| Ytd | 251.99% | |
| 1y | 537.98% |
12.75
day range
14.47
1.39
52 week range
15.88
| Open | 14.03 | Prev Close | 14.76 | Low | 12.75 | High | 14.47 | Mkt Cap | 2.61B |
| Vol | 11.09M | Avg Vol | 8.58M | EPS | -0.23 | P/E | N/A | Forward P/E | -88.47 |
| Beta | 2.53 | Short Ratio | 6.34 | Inst. Own | 27.67% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 7.59 | 200-d Avg | 4.29 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 9.25M | ||
| Research and Development Expense | 5.13M | ||
| Selling, General and Administrative Expense | 4.12M | ||
| Operating Income | -9.25M | ||
| Net Income | -8.41M | ||
| Net Income Common Stock | -8.41M | ||
| Net Income Common Stock (USD) | -8.41M | ||
| Consolidated Income | -8.41M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -8.41M | ||
| Earning Before Interest & Taxes (USD) | -8.41M | ||
| Weighted Average Shares | 172.48M | ||
| Weighted Average Shares Diluted | 172.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 107.20M | ||
| Cash and Equivalents (USD) | 107.20M | ||
| Current Assets | 111.17M | ||
| Property, Plant & Equipment Net | 839.00K | ||
| Total Assets | 114.18M | ||
| Debt Current | 562.00K | ||
| Total Debt | 871.00K | ||
| Current Liabilities | 6.46M | ||
| Debt Non-Current | 309.00K | ||
| Total Liabilities | 6.77M | ||
| Accumulated Retained Earnings (Deficit) | -283.39M | ||
| Shareholders Equity | 107.41M | ||
| Shareholders Equity (USD) | 107.41M | ||
| Assets Non-Current | 3.01M | ||
| Total Debt (USD) | 871.00K | ||
| Goodwill and Intangible Assets | 1.91M | ||
| Liabilities Non-Current | 309.00K | ||
| Trade and Non-Trade Payables | 3.63M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 153.00K | ||
| Net Cash Flow from Financing | 44.15M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 35.30M | ||
| Issuance (Purchase) of Equity Shares | 44.15M | ||
| Net Cash Flow from Operations | -8.85M | ||
| Share Based Compensation | 798.00K | ||